MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Nephros Cash and Cash Equivalents 2011-2026 | NEPH
Annual Cash and Cash Equivalents Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.31 M | 3.63 M | 6.97 M | 8.25 M | - | 4.58 M | 2.19 M | 275 K | 1.25 M | 1.28 M | 579 K | 47 K | 1.67 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 8.25 M | 47 K | 2.92 M |
Quarterly Cash and Cash Equivalents Nephros
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.17 M | 5.07 M | 4.08 M | 3.76 M | 2.46 M | 3.08 M | 3.63 M | 4.31 M | 4.62 M | 4.06 M | 3.84 M | 3.63 M | 3.94 M | 4.18 M | 5.42 M | 6.97 M | 7.35 M | 8.28 M | 8.16 M | 8.25 M | 8.25 M | 8.25 M | 8.25 M | 4.17 M | 4.17 M | 4.17 M | 4.17 M | 4.58 M | 4.58 M | 4.58 M | 4.58 M | 2.19 M | 2.19 M | 2.19 M | 2.19 M | 275 K | 275 K | 275 K | 275 K | 1.25 M | 1.25 M | 1.25 M | 1.25 M | 1.28 M | 1.28 M | 1.28 M | 1.28 M | 579 K | 579 K | 579 K | 579 K | 47 K | 47 K | 47 K | 47 K | 1.67 M | 1.67 M | 1.67 M | 1.67 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.28 M | 47 K | 3.21 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
1.76 B | $ 19.94 | 1.06 % | $ 10.2 B | USA |
 |
ICU Medical
ICUI
|
309 M | $ 149.15 | -0.59 % | $ 3.64 B | USA |
 |
Repro Med Systems
KRMD
|
11.5 M | $ 5.36 | -1.65 % | $ 244 M | USA |
 |
OraSure Technologies
OSUR
|
268 M | $ 2.76 | -1.08 % | $ 205 M | USA |
 |
Ekso Bionics Holdings
EKSO
|
6.49 M | $ 8.74 | 4.14 % | $ 176 M | USA |
 |
Alcon
ALC
|
1.68 B | $ 80.81 | -0.39 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
123 M | $ 36.51 | -1.19 % | $ 1.71 B | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 66.12 | 0.23 % | $ 3.33 B | USA |
 |
electroCore
ECOR
|
10.3 M | $ 6.56 | -7.61 % | $ 36.2 K | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 10.33 | 3.51 % | $ 422 M | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 8.25 | 2.61 % | $ 170 M | USA |
 |
STERIS plc
STE
|
172 M | $ 261.51 | -0.05 % | $ 25.8 B | USA |
 |
The Cooper Companies
COO
|
111 M | $ 80.56 | 0.24 % | $ 16 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 135.1 | -0.85 % | $ 7.2 B | USA |
 |
Harvard Bioscience
HBIO
|
4.28 M | $ 0.51 | -5.5 % | $ 21.6 M | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 118.29 | -0.56 % | $ 5.73 B | USA |
 |
Merit Medical Systems
MMSI
|
377 M | $ 81.27 | 1.28 % | $ 4.73 B | USA |
 |
Isoray
ISR
|
61.6 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
420 M | $ 152.4 | 2.29 % | $ 4.75 B | USA |
 |
LeMaitre Vascular
LMAT
|
25.6 M | $ 84.52 | 0.79 % | $ 1.9 B | USA |
 |
Intuitive Surgical
ISRG
|
2.03 B | $ 503.25 | -0.85 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
Utah Medical Products
UTMD
|
92.9 M | $ 61.3 | -0.57 % | $ 222 M | USA |
 |
Microbot Medical
MBOT
|
2.47 M | $ 1.82 | -2.16 % | $ 18.6 M |  Israel |
 |
Milestone Scientific
MLSS
|
3.26 M | $ 0.3 | -0.5 % | $ 23.9 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.07 B | $ 23.05 | -1.45 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 39.41 | 0.01 % | $ 130 M | USA |
 |
Predictive Oncology
POAI
|
735 K | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 13.67 | 0.37 % | $ 657 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 202.08 | 0.49 % | $ 58.1 B | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 150.45 | -3.79 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
274 M | $ 252.03 | -2.17 % | $ 36.8 B | USA |
 |
BioLife Solutions
BLFS
|
95.4 M | $ 22.01 | -2.52 % | $ 1.01 B | USA |
 |
Stereotaxis
STXS
|
19.8 M | $ 2.25 | -3.43 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
4.24 M | $ 0.69 | 0.36 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
144 M | $ 18.85 | -0.48 % | $ 926 M | USA |
 |
Teleflex Incorporated
TFX
|
290 M | $ 104.3 | -1.12 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
485 M | $ 228.04 | -1.98 % | $ 16.6 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
272 M | $ 12.36 | 0.73 % | $ 2.51 B | USA |